Table 2.

Frequency of D-loop single nucleotide polymorphisms in MDS patients and healthy controls.

Nucleotide positionNucleotide variantHypervariable regionMDS (n = 44)Healthy controls (n = 43)
16129G→AHV113 (29.5%)8 (18.6%)
16172T→CHV16( 13.6%)9 (20.9%)
16183A→CHV111 (25.0%)6 (14.0%)
16189T→CHV118 (40.9%)*9 (20.9 %)*
16223C→THV132 (72.7%)36 (83.7 %)
16298T→CHV16 (13.6%)5 (11.6%)
16304T→CHV17 (15.9%)4 (9.3% )
16319G→AHV18 (18.2%)6 (14.0%)
16362T→CHV115 (34.1%)18 (41.9%)
73A→GHV244 (100%)43 (100%)
146T→CHV28 (18.2%)5 (11.6%)
150C→THV210 (22.7%)9 (20.9%)
152T→CHV25 (11.4%)7 (16.3%)
263A→GHV244 (100%)43 (100%)
303T insertionHV231 (70.5%)27 (62.8%)
315T insertionHV238 (86.4%)36(83.7%)
  • MDS, myelodysplastic syndrome;

  • * P < 0.05